Skip to main content
Clinical Trials/NCT06427603
NCT06427603RecruitingNot Applicable

Sit Less and Move More: A Feasibility Study on Physical Active Break Intervention and Improving Cardiometabolic Health

Hong Kong Metropolitan University1 site in 1 country30 target enrollmentStarted: October 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
30
Locations
1
Primary Endpoint
Intervention feasibility

Study Overview

Brief Summary

Intervention aiming to improve cardiometabolic health and physical function by reducing prolonged sitting

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None (Participant, Investigator)

Eligibility Criteria

Ages
65 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •are community-dwelling older adults aged 65 years or above,
  • •are smartphone users,
  • •sit for >= 6 hours per day
  • •are overweight

Exclusion Criteria

  • •are unable to walk independently with/without walking aids due to a physical disability;
  • •have health conditions that hinder the adherence to intervention

Arms & Interventions

activity group

Experimental

Intervention: physical activity (Behavioral)

Outcomes

Primary Outcomes

Intervention feasibility

Time Frame: T2: post-intervention (week 12)

will be assessed using a scale "Feasibility, appropriateness, and acceptability of the intervention"

Secondary Outcomes

  • Physical activity(T2: post-intervention (week 12))
  • Muscle strength (handgrip strength)(T2: post-intervention (week 12))
  • Physical performance(T2: post-intervention (week 12))
  • Sedentary behavior(T2: post-intervention (week 12))
  • Sarcopenia score ranged from 0 to 20(T2: post-intervention (week 12))
  • Blood glucose(T2: post-intervention (week 12))
  • Blood pressure(T2: post-intervention (week 12))
  • Sedentary behavior(T2: post-intervention (week 12))
  • Sarcopenia score ranged from 0 to 20(T2: post-intervention (week 12))
  • Blood glucose(T2: post-intervention (week 12))
  • Blood pressure(T2: post-intervention (week 12))
  • Muscle strength (handgrip strength)(T2: post-intervention (week 12))
  • Physical performance(T2: post-intervention (week 12))
  • physical function(T2: post-intervention (week 12))
  • Standing(T2: post-intervention (week 12))
  • Sedentary behavior(T1: baseline (before the study begins))
  • Sarcopenia score ranged from 0 to 20(T1: baseline (before the study begins))
  • Blood glucose(T1: baseline (before the study begins))
  • Blood pressure(T1: baseline (before the study begins))
  • Muscle strength (handgrip strength)(T1: baseline (before the study begins))
  • Physical performance(T1: baseline (before the study begins))
  • physical function(T1: baseline (before the study begins))
  • Physical activity(T1: baseline (before the study begins))
  • Standing(T1: baseline (before the study begins))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr Bonny WONG Yee Man

Assistant Professor

Hong Kong Metropolitan University

Study Sites (1)

Loading locations...

Similar Trials